F/m Emerald Life Sciences Innovation ETF Rating $21.06 -0.17 (-0.81%) Closing price 03:51 PM EasternExtended Trading$21.06 +0.00 (+0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.94Holdings in LFSC have an aggregate rating of Moderate Buy based on 330 analyst ratings issued in the past year covering 29 companies (99.1% of the portfolio).LFSC Aggregate Price Target$21.06High Prediction$21.06Average Prediction$21.06Low Prediction$21.06Holdings in LFSC have an aggregate price target of $21.06 and a range of $21.06 to $21.06 covering 29 companies (99.1% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.62%BBIOBridgeBio Pharma$34.24-1.8%4.5723 of 5 stars2.92$53.00 54.8%12Analyst ForecastPositive News7.27%SLNOSoleno Therapeutics$70.25+0.4%4.7854 of 5 stars3.22$99.63 41.8%9Analyst ForecastPositive News6.99%RDNTRadNet$53.08-0.5%3.828 of 5 stars3.40$69.75 31.4%5News CoveragePositive News6.10%BPMCBlueprint Medicines$81.45-1.3%2.6248 of 5 stars2.70$124.95 53.4%23Positive News5.78%MMSIMerit Medical Systems$91.96-1.4%4.4906 of 5 stars3.00$114.33 24.3%10Short Interest ↓Positive News4.80%LIVNLivaNova$34.80-1.9%3.5551 of 5 stars2.88$61.17 75.8%8News CoveragePositive News4.65%TMDXTransMedics Group$87.18+0.4%2.7651 of 5 stars2.82$122.70 40.7%114.54%TVTXTravere Therapeutics$14.91+0.5%2.559 of 5 stars2.93$32.08 115.1%14Analyst Forecast4.41%RAREUltragenyx Pharmaceutical$35.34+1.2%4.5537 of 5 stars2.93$92.79 162.6%14Positive NewsGap Down4.37%COLLCollegium Pharmaceutical$27.12+1.5%4.1648 of 5 stars2.80$43.60 60.8%5News CoveragePositive NewsGap Down4.19%MDGLMadrigal Pharmaceuticals$321.10-0.4%4.0481 of 5 stars2.80$378.44 17.9%10News CoveragePositive News3.87%INSMInsmed$71.07+0.1%4.1144 of 5 stars3.00$94.00 32.3%16Positive News3.73%ATECAlphatec$9.91-2.7%3.941 of 5 stars2.89$17.67 78.3%9Analyst ForecastOptions VolumeNews Coverage3.62%GHGuardant Health$44.85-0.7%3.6829 of 5 stars3.05$49.00 9.3%213.01%WVEWave Life Sciences$6.28+4.7%4.1802 of 5 stars3.00$22.18 253.2%11Short Interest ↑Analyst Revision2.45%ETNB89bio$6.05+2.2%2.5806 of 5 stars2.90$27.56 355.5%10Short Interest ↑News CoverageGap Down2.27%AKROAkero Therapeutics$38.08+1.3%4.307 of 5 stars3.00$76.29 100.3%9Positive News2.21%ACADACADIA Pharmaceuticals$14.99+0.9%4.0179 of 5 stars2.50$23.93 59.7%16Analyst RevisionNews CoveragePositive NewsGap Down2.21%NEONeoGenomics$9.50-2.3%2.5627 of 5 stars2.80$19.60 106.3%10News Coverage2.18%GMEDGlobus Medical$72.29-1.0%4.7611 of 5 stars2.75$96.91 34.1%12Short Interest ↑News CoveragePositive NewsGap Down2.06%SRPTSarepta Therapeutics$54.42-0.4%4.6743 of 5 stars2.83$161.83 197.4%24Short Interest ↑1.65%BHVNBiohaven$18.56+0.3%3.5018 of 5 stars3.07$62.77 238.1%151.62%UTHRUnited Therapeutics$284.82+0.2%4.9019 of 5 stars2.67$388.25 36.3%12Insider TradeNews CoveragePositive NewsGap Down1.41%SYRESpyre Therapeutics$12.71-2.4%1.6492 of 5 stars3.20$49.57 290.0%101.34%SVRASavara$2.93+1.0%2.3487 of 5 stars2.83$8.83 201.5%6Positive News1.25%NVCRNovoCure$16.46-0.5%3.3286 of 5 stars2.67$34.50 109.6%6News Coverage1.20%KALVKalVista Pharmaceuticals$12.02+0.6%4.1787 of 5 stars3.13$24.83 106.6%81.18%OFIXOrthofix Medical$13.41-0.5%2.9048 of 5 stars2.80$23.33 74.0%5Positive News1.11%ITGRInteger$116.84-1.0%2.2704 of 5 stars2.78$146.00 25.0%9Positive NewsGap DownHigh Trading Volume This page (NASDAQ:LFSC) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
